STTK Stock Price, Shattuck Labs Inc Quote, Chart

Market Summary

USD9.39-0.19

Delayedas of 22 Apr 2024, 01:03 pm

-1.98%

STTK Stock Price

View Fullscreen

STTK RSI Chart

STTK Valuation

Market Cap

454.8M

Price/Earnings (Trailing)

-5.21

Price/Sales (Trailing)

274.48

Price/Free Cashflow

-5.57

STTK Price/Sales (Trailing)

STTK Profitability

Return on Equity

-60.33%

Return on Assets

-54.71%

Free Cashflow Yield

-17.95%

STTK Fundamentals

STTK Revenue

Revenue (TTM)

1.7M

Rev. Growth (Yr)

83.08%

Rev. Growth (Qtr)

4.08%

STTK Earnings

Earnings (TTM)

-87.3M

Earnings Growth (Yr)

30.4%

Earnings Growth (Qtr)

35.78%

Breaking Down STTK Revenue

52 Week Range

1.369.75

(Low)(High)

Last 7 days

2.8%

Last 30 days

1.4%

Last 90 days

6.4%

Trailing 12 Months

242.9%

How does STTK drawdown profile look like?

STTK Financial Health

Current Ratio

12.51

STTK Investor Care

Shares Dilution (1Y)

11.84%

Diluted EPS (TTM)

-2.05

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2023	755.5K	859.0K	1.3M	1.7M
2022	0	20.2M	10.4M	652.0K
2021	9.2M	0	7.9M	30.0M
2020	9.9M	9.9M	9.9M	9.9M
2019	0	0	0	9.9M

Get all data in R, Python etc through our Historical Stock Data APIs

GRUFITY'S FAIR VALUE MODEL

Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed Russell 2000 Index

Small Caps and Mid Caps are mostly overlooked by investors as all the focus goes to Magnificent 7. These stocks that are not part of the beauty contest require a deeper look. However, all large cap stocks were once small caps. Grufity's Fair Value model opens up this unverse as it separates high-performing, rewarding stocks from low-performing risky stocks. <b>Russell 2000 stocks that were marked 'Very Cheap' by the model doubled in three years while the index was flat.</b>

Returns of $10,000 invested in:

Very Cheap Stocks: $21,859
Russell 2000 Index: $10,334
Very Expensive Stocks: $8,224

Russell 2000 stocks considered 'Very Cheap' by the model greatly outperformed Russell 2000 index and the 'Very Expensive' bucket over past three years.

Russell 2000 Index

Very Expensive Stocks

Very Cheap Stocks

Try For Just $1.99

Tracking the Latest Insider Buys and Sells of Shattuck Labs Inc

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
Mar 28, 2024	redmile group, llc	sold	-	-	-4,425	-
Mar 06, 2024	stout stephen	sold	-168,522	10.53	-16,004	see remarks
Mar 06, 2024	stout stephen	acquired	39,380	3.54489	11,109	see remarks
Jan 30, 2024	pandite arundathy n.	sold (taxes)	-29,170	9.99	-2,920	chief medical officer
Jan 30, 2024	stout stephen	sold (taxes)	-5,924	9.99	-593	see remarks
Jan 30, 2024	shukla abhinav a.	sold (taxes)	-22,877	9.99	-2,290	chief technical officer
Jan 30, 2024	deyoung casi	sold (taxes)	-20,059	9.99	-2,008	chief business officer
Jan 10, 2024	pandite arundathy n.	sold (taxes)	-30,138	10.09	-2,987	chief medical officer
Jan 10, 2024	neill andrew r	acquired	-	-	56,500	chief financial officer
Jan 10, 2024	neill andrew r	sold (taxes)	-24,922	10.09	-2,470	chief financial officer

Which funds bought or sold STTK recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
Apr 17, 2024	Cannon Global Investment Management, LLC	new	-	91,188	91,188	0.24%
Apr 16, 2024	Reliant Investment Management, LLC	unchanged	-	36,200	178,800	0.08%
Mar 11, 2024	VANGUARD GROUP INC	added	12.21	7,606,600	9,390,680	-%
Mar 01, 2024	GOLDMAN SACHS GROUP INC	new	-	210,834	210,834	-%
Feb 28, 2024	UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGMENT CO	new	-	7,000	7,000	-%
Feb 16, 2024	PRICE T ROWE ASSOCIATES INC /MD/	unchanged	-	108,000	138,000	-%
Feb 15, 2024	JANE STREET GROUP, LLC	new	-	211,904	211,904	-%
Feb 15, 2024	Exome Asset Management LLC	new	-	1,592,130	1,592,130	1.57%
Feb 15, 2024	BARCLAYS PLC	sold off	-100	-25,000	-	-%
Feb 14, 2024	BRIDGEWAY CAPITAL MANAGEMENT, LLC	reduced	-48.03	210,685	357,213	0.01%

Are Funds Buying or Selling STTK?

Are funds buying STTK calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own STTK

No. of Funds

Unveiling Shattuck Labs Inc's Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Feb 09, 2024	fmr llc	-	0	SC 13G/A
Jan 29, 2024	adage capital partners gp, l.l.c.	5.47%	2,577,705	SC 13G
Jan 02, 2024	prosight management, lp	5.9%	2,782,797	SC 13G
Dec 26, 2023	redmile group, llc	12.0%	5,664,892	SC 13D/A
Feb 09, 2023	fmr llc	-	0	SC 13G/A
Dec 09, 2022	hornblower josiah	7.0%	2,977,627	SC 13D/A
Jun 09, 2022	blackrock inc.	4.97%	2,110,075	SC 13G
Feb 14, 2022	ecor1 capital, llc	0%	0	SC 13G/A
Feb 09, 2022	fmr llc	-	0	SC 13G/A
Feb 04, 2022	blackrock inc.	5.2%	2,209,819	SC 13G

Recent SEC filings of Shattuck Labs Inc

View All Filings

Date Filed	Form Type	Document
Apr 01, 2024	4	Insider Trading
Mar 08, 2024	3	Insider Trading
Mar 08, 2024	3	Insider Trading
Mar 08, 2024	4	Insider Trading
Mar 08, 2024	4	Insider Trading
Mar 08, 2024	4	Insider Trading
Mar 06, 2024	144	Notice of Insider Sale Intent
Mar 04, 2024	8-K	Current Report
Feb 29, 2024	10-K	Annual Report
Feb 29, 2024	8-K	Current Report

Peers (Alternatives to Shattuck Labs Inc)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
MRNA	38.7B	6.8B	-1.66%	-28.18%	-8.22	5.66	-64.45%	-156.37%
HILS	22.4B	152.6K	-0.77%	465779.94%	-2.4K	146.8K	-	-9.98%
ALNY	18.2B	1.8B	-2.46%	-28.84%	-41.3	9.94	76.23%	61.08%
BMRN	16.7B	2.4B	4.57%	-8.46%	99.75	6.91	15.42%	18.43%
INCY	11.8B	3.7B	-10.11%	-29.11%	19.67	3.18	8.87%	75.42%
MID-CAP
APLS	5.7B	396.6M	-14.37%	-42.33%	-10.84	14.45	425.83%	18.94%
BBIO	4.4B	-	-13.59%	50.21%	-6.66	60.35	54.84%	-34.79%
AXSM	3.2B	270.6M	-13.81%	-4.67%	-13.45	11.89	440.80%	-27.84%
ACAD	2.8B	726.4M	-9.91%	-15.82%	-45.22	3.82	40.45%	71.62%
ARWR	2.8B	240.7M	-20.67%	-25.33%	-9.32	12.18	-1.03%	-92.09%
SMALL-CAP
CPRX	1.8B	398.2M	-10.64%	-8.42%	24.94	4.47	85.90%	-14.05%
NVAX	558.4M	983.7M	-17.39%	-51.52%	-1.02	0.57	-50.36%	17.16%
CRBP	409.4M	881.7K	-0.38%	387.14%	-9.18	466.16	-77.61%	-5.33%
INO	226.2M	4.9M	-10.29%	-2.81%	-1.67	46.49	-54.97%	51.71%
IBIO	6.0M	2.1M	59.81%	33.59%	-0.22	2.14	-13.45%	66.37%

Shattuck Labs Inc News

Latest updates

Shattuck Labs Inc Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Income Statement (Quarterly)																(In Thousands)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2021Q4	2021Q3	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3
Revenue	4.1%	714	686	200	57.00	390	212	775	1,337	1,900	2,270	1,342	2,435	3,181	2,976	2,380	1,784
Operating Expenses	-32.8%	19,665	29,284	22,947	21,718	26,666	25,441	27,708	20,832	19,480	14,693	13,353	14,274	9,501	9,737	-	9,311
S&GA Expenses	-12.5%	4,438	5,073	4,742	5,051	4,779	6,579	4,745	4,625	4,343	4,356	3,566	2,470	1,746	1,600	-	1,366
R&D Expenses	-37.1%	15,227	24,211	18,205	16,667	21,887	18,862	22,963	16,207	15,137	10,337	9,787	11,804	7,755	8,137	-	7,945
Net Income	35.8%	-17,687	-27,541	-21,346	-20,724	-25,411	-24,635	-27,371	7,847	-17,410	-11,813	-12,012	-11,829	-6,208	-6,554	-7,369	-7,279
Net Income Margin	26.1%	-52.68*	-71.28*	-107.24*	-129.90*	-156.36*	-8.59*	-4.01*	-1.50*	-2.81*	-4.54*	-	-	-	-	-	-
Free Cashflow	-16.0%	-19,436	-16,751	-18,912	-26,536	-24,534	-28,814	-23,999	-20,707	-13,956	-13,706	-	-	-	-	-	-

Balance Sheet

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet															(In Millions)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2019Q4
Assets	22.3%	160	130	155	178	205	223	251	270	299	311	324	337	349	145	45.00
Current Assets	26.8%	143	113	136	158	185	202	229	255	288	302	316	331	346	142	42.00
Cash Equivalents	209.2%	126	41.00	72.00	66.00	47.00	40.00	38.00	51.00	92.00	85.00	86.00	85.00	158	129	7.00
Net PPE	-6.7%	14.00	15.00	16.00	17.00	18.00	18.00	19.00	12.00	10.00	9.00	8.00	5.00	3.00	3.00	2.00
Liabilities	-15.9%	15.00	18.00	17.00	20.00	29.00	24.00	29.00	22.00	27.00	49.00	47.00	38.00	39.00	37.00	30.00
Current Liabilities	-18.5%	11.00	14.00	13.00	16.00	25.00	19.00	24.00	17.00	25.00	20.00	15.00	18.00	17.00	16.00	20.00
Shareholder's Equity	28.3%	145	113	138	158	176	199	223	249	272	261	277	299	310	-	-
Retained Earnings	-6.1%	-306	-288	-261	-239	-219	-193	-169	-141	-117	-124	-107	-83.90	-72.09	-60.10	-35.49
Additional Paid-In Capital	12.4%	451	401	400	398	396	394	393	391	389	388	386	383	382	2.00	1.00
Shares Outstanding	11.2%	47.00	42.00	42.00	42.00	42.00	42.00	42.00	42.00	42.00	42.00	42.00	42.00	-	-	-
Float	-	-	-	86.00	-	-	-	111	-	-	-	690	-	-	554	-

Cashflow (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Cashflow (Quarterly)																		(In Thousands)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3
Cashflow From Operations	-16.1%	-19,419	-16,732	-18,616	-26,461	-23,841	-28,064	-16,316	-26,277	-18,717	-12,992	-14,339	-11,068	-14,043	-11,348	2,185	-10,453	-	-
Share Based Compensation	-7.0%	1,640	1,764	1,852	1,683	1,693	1,723	1,533	1,513	1,216	1,344	1,727	1,180	637	312	143	174	-	-
Cashflow From Investing	483.9%	55,851	-14,550	24,433	45,125	31,462	29,925	3,433	-15,382	25,601	11,240	14,843	-62,127	-171,488	9,987	8,481	6,698	-	-
Cashflow From Financing	231147.6%	48,562	21.00	33.00	-	-	27.00	10.00	134	290	352	1,256	31.00	214,829	-1,083	82,687	34,433	-	-

STTK Income Statement

2023-12-31

STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Income Statement [Abstract]
Revenue from Contract with Customer, Product and Service [Extensible List]	License [Member]	License [Member]
Collaboration revenue	$ 1,657	$ 652
Operating expenses:
Research and development	74,310	82,899
General and administrative	19,304	21,082
Expense from operations	93,614	103,981
Loss from operations	(91,957)	(103,329)
Other income (expense):
Interest income	4,669	1,592
Other	(10)	(208)
Total other income	4,659	1,384
Net loss	(87,298)	(101,945)
Unrealized gain (loss) on investments	881	(317)
Comprehensive loss	$ (86,417)	$ (102,262)
Net loss per share – basic (in dollars per share)	$ (2.05)	$ (2.41)
Net loss per share – diluted (in dollars per share)	$ (2.05)	$ (2.41)
Weighted-average shares outstanding - basic (in shares)	42,600,190	42,378,895
Weighted-average shares outstanding - diluted (in shares)	42,600,190	42,378,895

STTK Balance Sheet

2023-12-31

BALANCE SHEETS - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Current assets:
Cash and cash equivalents	$ 125,626	$ 47,379
Investments	4,999	113,901
Prepaid expenses and other current assets	12,595	23,304
Total current assets	143,220	184,584
Property and equipment, net	13,804	17,671
Other assets	2,540	3,069
Total assets	159,564	205,324
Current liabilities:
Accounts payable	1,587	7,170
Accrued expenses and other current liabilities	9,866	17,795
Total current liabilities	11,453	24,965
Non-current operating lease liabilities	3,406	4,202
Total liabilities	14,859	29,167
Commitments and contingencies (Note 7)
Stockholders’ equity:
Common stock, $0.0001 par value: 300,000,000 shares authorized, 47,260,108 shares issued and outstanding at December 31, 2023 and 42,390,586 shares issued and outstanding at December 31, 2022	5	5
Additional paid-in capital	451,006	396,041
Accumulated other comprehensive income (loss)	4	(877)
Accumulated deficit	(306,310)	(219,012)
Total stockholders’ equity	144,705	176,157
Total liabilities and stockholders’ equity	$ 159,564	$ 205,324

About Shattuck Labs Inc

Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers. The company was incorporated in 2016 and is headquartered in Austin, Texas.

CEO	Dr. Taylor H. Schreiber M.D., Ph.D.
WEBSITE	shattucklabs.com
INDUSTRY	Biotechnology
EMPLOYEES	105

Shattuck Labs Inc Frequently Asked Questions

What is the ticker symbol for Shattuck Labs Inc? What does STTK stand for in stocks?

STTK is the stock ticker symbol of Shattuck Labs Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Shattuck Labs Inc (STTK)?

As of Fri Apr 19 2024, market cap of Shattuck Labs Inc is 454.81 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of STTK stock?

You can check STTK's fair value in chart for subscribers.

What is the fair value of STTK stock?

You can check STTK's fair value in chart for subscribers. The fair value of Shattuck Labs Inc is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Shattuck Labs Inc is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for STTK so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Shattuck Labs Inc a good stock to buy?

The fair value guage provides a quick view whether STTK is over valued or under valued. Whether Shattuck Labs Inc is cheap or expensive depends on the assumptions which impact Shattuck Labs Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for STTK.

What is Shattuck Labs Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri Apr 19 2024, STTK's PE ratio (Price to Earnings) is -5.21 and Price to Sales (PS) ratio is 274.48. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. STTK PE ratio will change depending on the future growth rate expectations of investors.